Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vital ChemtechNSE:VITAL 77 Receivables Turnover is 0.79 as of Mar. 2026. GuruFocus rates NSE:VITAL with a GF Score™ of 77/100 and a GF Value™ of ₹83.34 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 1,577 Chemicals companies, Vital Chemtech ranks worse than 95.94% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Vital Chemtech's Revenue for the
six
months ended in Mar. 2026 was ₹351.4 Mil. Vital Chemtech's average Accounts Receivable for the
six
months ended in Mar. 2026 was ₹443.4 Mil.
Hence, Vital Chemtech's Receivables Turnover for the
six
months ended in Mar. 2026 was 0.79.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Vital Chemtech Receivables Turnover Related Terms
Vital Chemtech Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Vital Chemtech's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:VITAL vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Vital Chemtech's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital Chemtech Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vital Chemtech's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Vital Chemtech's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital Chemtech (NSE:VITAL) has a Receivables Turnover of 0.79 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vital Chemtech and its competitors. According to the industry distribution chart, Vital Chemtech ranks #1513 out of 1577 companies in the Chemicals industry, placing it in the top 95.9%.
Is Vital Chemtech's Receivables Turnover too high?
Vital Chemtech's current Receivables Turnover is 0.79. The Chemicals industry median Receivables Turnover is 5.60. Vital Chemtech's value of 0.79 is 85.9% below this industry median. Based on the distribution chart, Vital Chemtech ranks #1513 out of 1577 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vital Chemtech has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vital Chemtech's Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Vital Chemtech ranks #1513 out of 1577 companies for Receivables Turnover. This places Vital Chemtech in the lower half of its industry. The industry median Receivables Turnover is 5.60. Vital Chemtech's value of 0.79 is 85.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.60, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital Chemtech's current Receivables Turnover of 0.79 is 85.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vital Chemtech and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital Chemtech's current Receivables Turnover is 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital Chemtech stock overvalued right now?
Based on GuruFocus' analysis, Vital Chemtech (NSE:VITAL) is currently considered Possible Value Trap. The stock's GF Value™ is ₹83.34, compared to a current price of ₹46.00 — trading 44.8% below its estimated fair value. The current Receivables Turnover is 0.79 and 85.9% below the Chemicals industry median of 5.60. Vital Chemtech's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Vital Chemtech (NSE:VITAL), the current Receivables Turnover is 0.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital Chemtech (NSE:VITAL) Overvalued in 2026?
Based on GuruFocus' analysis, Vital Chemtech stock appears to be undervalued.
The current stock price of ₹46.00 is trading 44.8% below its estimated GF Value™ of ₹83.34.
GuruFocus considers Vital Chemtech to be Possible Value Trap.
Key valuation signals for NSE:VITAL:
Receivables Turnover: 0.79
GF Value™: ₹83.34 vs. price of ₹46.00 (44.8% below fair value)
Industry Position: 85.9% below the Chemicals median (#1513 of 1577)
No single metric tells the full story. See the NSE:VITAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital Chemtech Ltd is engaged in the business of manufacturing, producing, refining, processing, formulating, mixing, enriching, mining, importing, exporting, acquiring, inventing, buying, selling, exchanging, distributing, and otherwise trading and dealing in all kinds of mixtures, formlations, intermediates, derivatives, compounds, phosphorous based chemicals, fine chemicals, heavy chemicals, valence, inorganic and organic chemicals, source materials, intermediates, ingredients, mixtures, derivatives and compounds. The company's Products include Phosphorus Derivatives, Industrial Chemicals, Specialty Chemicals & Intermediates, Organophosphates, Polymers & Dispersants, and Wellness Products.
77GF Score
Get the complete analysis for NSE:VITAL
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VITAL has been successfully added to your 
